Navigation Links
The Dark Report and Siemens Introduce the World's First Integrated Molecular Summit
Date:1/28/2008

Thomas Miller, CEO Workflow and Solutions Division, Siemens Healthcare, to

Serve as Event Keynote Speaker

PHILADELPHIA, Jan. 28 /PRNewswire-FirstCall/ -- Recent advances in genetic knowledge are transforming molecular imaging, molecular diagnostics and informatics to create stunningly precise diagnostic tools capable of assessing and treating a growing number of critical diseases. These new diagnostic tools provide physicians with an understanding of individual patient or disease differences at the molecular or genetic level, enabling them to leverage predictive diagnosis and tailor effective treatment to the individual.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

To address this new frontier in healthcare, Thomas Miller, CEO of Siemens Healthcare's Workflow and Solutions Division, will serve as a keynote speaker at the first international Molecular Summit on the integration of in vivo and in vitro diagnostics on February 5-6, 2008, at the Sheraton Society Hill Hotel in Philadelphia.

Miller will discuss Siemens' vision for a new era in medicine, one enabled through integration of molecular imaging, molecular diagnostics and informatics, specifically how the integration of these disciplines will lead to predictive diagnosis and individualized treatment - true personalized medicine, which will result in improved patient outcomes. Additionally, he will speak about Siemens' business strategy for becoming the world's first and pre-eminent leader in in vivo and in vitro diagnostics

About the Summit

The Dark Report and Siemens have assembled an international faculty of experts and early adopters of integrated diagnostic care pathways within radiology and pathology to address the first international Molecular Summit on the integration of in vivo and in vitro diagnostics.

Conference attendees
'/>"/>

SOURCE Siemens
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Varian, Inc. Reports First Quarter 2008 Results
2. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
3. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
4. VNUS Medical Technologies to Report Fourth-Quarter 2007 Results and Webcast Teleconference on February 7
5. Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results
6. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
7. Pharmasset Reports Fiscal Year End 2007 Financial Results
8. Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
10. Imagenetix Reports Results of Offer to Extend Warrants
11. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its preliminary unaudited financial results for the fourth ... March 31, 2013. Fourth Quarter of ... quarter of fiscal 2013 increased by 33.3% to RMB133.0 ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 In support ... sustainability, the Consulate General of Switzerland in New York ... Switzerland’s MS Tûranor PlanetSolar , to Manhattan. ... its DeepWater Expedition 2013 tour with scientists on board ... Capitain Gérard d’Aboville, runs exclusively on energy from the ...
(Date:6/18/2013)... 18, 2013 (PRWEB) June 18, 2013 ... attendance system in North America, has introduced AccountLinx ... data and payroll records between ExakTime’s software and ... automates ExakTime software setup and keeps employee databases ... data from a business’ current payroll software, directly ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The ... opening of two new offices in Asia—one in Singapore ... will serve as RAPS’ Pan-Asia office , serving ... be more focused on audiences within China. , The ... its partnership with five Singapore government agencies to develop ...
Breaking Biology Technology:China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4ExakTime Introduces AccountLinx Plus 2RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3
... Inc.,(Nasdaq: NGSX ), a biopharmaceutical company focused ... appointment of Bruce A.,Peacock to the NeurogesX board ... a venture partner with SV Life Sciences, LLC. ... Peacock held senior executive,positions with a number of ...
... 5 Hyperion,Therapeutics, a biopharmaceutical company focused on ... for the,treatment of Urea Cycle Disorders (UCD) and ... B financing. Leading the round was,Sofinnova Ventures, with ... of Menlo Park, CA. WRF Capital of Seattle, ...
... - World,s First Closed-Chest Procedures with Cardica,s C-Port Flex A ... ... REDWOOD CITY, Calif., Sept. 5 Cardica, Inc.,(Nasdaq: CRDC ... performed ground-breaking minimally-invasive,closed-chest bypass procedures using Cardica,s C-Port Flex A ...
Cached Biology Technology:NeurogesX Appoints New Director to the Board 2NeurogesX Appoints New Director to the Board 3Hyperion Therapeutics Secures $40 Million In Series B Round 2Cardica's C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries 2Cardica's C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries 3Cardica's C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries 4
(Date:6/18/2013)... Researchers from the United Kingdom, the Energy Department,s ... of Kentucky have recently published a paper describing ... borer Limnoria quadripunctata , commonly known as ... because they exhibit a relatively unique ability to ... microbes to break down the biomass they eat. ...
(Date:6/18/2013)... been awarded a $394,300 grant from the Tarrant ... flow in the new facilities of the 150-mile ... associate professor of civil engineering, will investigate the ... the water in an effort to eliminate biological ... Adding monochloramine is widely practiced throughout the United ...
(Date:6/18/2013)... At Brandeis University, sophisticated computational models and advances ... the complex interplay between genomic data, virus structure ... critical for replication. , "We ... will help researchers alter virus assembly, leaving viruses ... first author of the scientific paper describing the ...
Breaking Biology News(10 mins):Novel enzyme from tiny gribble could prove a boon for biofuels research 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2Computer modeling technique goes viral at Brandeis 2
... S. Perrone, J. M. Rubi, and D. Petrov, Physical ... often easier to keep your kids under control by exerting ... in a confining booster seat, for example, may be perfectly ... at the Universitat de Barcelona has found that the same ...
... ALAMOS, New Mexico, May 4, 2008A spidery fungus with ... could hold the key to improvements in the production ... researchers has announced. In a paper published today ... Laboratory and the U.S. Department of Energy Joint Genome ...
... of self-digestion called autophagy prompts the maturation of red ... would not effectively rid themselves of organelles called mitochondria ... at Baylor College of Medicine in Houston in a ... Its changed our thinking on autophagy, said ...
Cached Biology News:A gentle touch for better control, a quantum mechanical con, and milestone PRL papers 2A gentle touch for better control, a quantum mechanical con, and milestone PRL papers 3A gentle touch for better control, a quantum mechanical con, and milestone PRL papers 4Turning fungus into fuel 2Nixing immaturity in red blood cells 2
... LNA technology enables sensitive and specific detection ... miRCURY LNA in situ detection probes have ... specific and sensitive detection of miRNAs. Specific ... in whole mounts, thin sections, single cells ...
... kit contains enough separation reagents ... total of 5 x 10 ... the StemSep red magnet and ... buffers for the specific cell ...
... Product Mouse monoclonal [1320] to RFC1 ... p37 subunit of human Replication Factor C expressed ... Cross-reacts with Human and S. cerevisiae. Not yet ... p37 subunit of RFC1 Background Information ...
... a K-12 strain ideally suited as an ... transformation efficiency, blue/white screening capability (with appropriate ... in high yields of excellent quality plasmid ... potentially useful as a stringent host due ...
Biology Products: